5 Am Venture Management, LLC Iveric Bio, Inc. Transaction History

5 Am Venture Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $1.87 Million - $2.46 Million	-100,000 Reduced 26.0%	284,626 $6.92 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $2.14 Million - $2.98 Million	-124,221 Reduced 24.41%	384,626 $8.23 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $4.88 Million - $9.65 Million	-519,027 Reduced 50.5%	508,847 $9.13 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $4.67 Million - $6.47 Million	384,626 Added 59.79%	1,027,874 $17.3 Million
Q4 2021 Feb 03, 2022	SELL	$13.83 - $18.78 $1.75 Million - $2.38 Million	-126,752 Reduced 16.46%	643,248 $10.8 Million

Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $5.44 Million - $13.5 Million	770,000 New	770,000 $12.5 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 5 Am Venture Management, LLC with notifications on news.